New cases over time.
Measures the occurrence of new outcomes among people at risk.
Side 42
A study of health patterns in populations. Epidemiology measures who experiences an outcome, when and where it occurs, which exposures differ between groups, and how confidently those differences support causal or preventive conclusions.
Counts alone do not reveal risk. Epidemiology relates events to the population and time at risk.
Measures the occurrence of new outcomes among people at risk.
Reflects both incidence and how long the condition persists.
Requires a clearly defined population initially at risk.
Useful when follow-up time differs across individuals.
Cause-specific mortality depends on consistent classification of deaths.
Depends heavily on who is diagnosed and how cases are defined.
Different designs trade speed, cost, control and susceptibility to bias.
| Design | Starts with | Strength | Main caution |
|---|---|---|---|
| Cross-sectional | Population snapshot | Prevalence and associations | Weak temporal ordering |
| Cohort | Exposure groups | Incidence and temporal sequence | Confounding and loss to follow-up |
| Case-control | Outcome status | Efficient for rare outcomes | Selection and exposure recall |
| Randomized trial | Assigned intervention | Strong causal identification | Generalizability, compliance, ethics |
| Ecological | Group-level exposure/outcome | Population patterns | Group associations may not hold for individuals |
A large relative effect can correspond to a small absolute change when baseline risk is low.
Risk in exposed divided by risk in unexposed.
Exposed risk minus unexposed risk shows absolute excess or reduction.
Useful when groups contribute different amounts of person-time.
Common in case-control studies; can diverge from risk ratio when outcomes are common.
Depends on both effect size and exposure prevalence.
Communicating both helps prevent dramatic percentage changes from obscuring a small baseline probability.
The central question is whether compared groups differ in ways that distort the exposure–outcome relationship.
The analyzed sample may no longer represent the intended comparison.
The crude association can mix causal effect with baseline differences.
Differential error can distort estimates in unpredictable directions.
Cases may remember prior exposures differently from controls.
More testing can produce more diagnosed cases without more underlying disease.
Restricting on a common effect of exposure and outcome-related causes can induce bias.
The goal is to characterize spread, identify likely sources and interrupt transmission while evidence is still incomplete.
Observed versus expected.
Changes in testing or reporting can mimic an outbreak.
Person, place, time, criteria.
Case definitions trade sensitivity against specificity.
Epidemic curve + map.
Descriptive patterns generate hypotheses about source and transmission.
Cohort or case-control analysis.
Analytic studies test hypotheses generated by the descriptive phase.
Act before perfect certainty.
Public-health control often proceeds alongside continued investigation.
Effect estimates mean little without understanding the population, comparison and sources of bias.
Ask for baseline risk, absolute difference, confidence interval, exposure definition, confounder control and whether the design establishes temporal order.
Check testing volume, reporting changes, seasonality, population size and whether the comparison month is representative.
More detection can reflect earlier or more intensive diagnosis rather than increased underlying incidence; lead-time and overdiagnosis may matter.
Still inspect allocation concealment, attrition, adherence, outcome definition, blinding where possible, and whether the trial population resembles the population of interest.